| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |